4//SEC Filing
WATSON PHARMACEUTICALS INC 4
Accession 0001179110-05-019121
CIK 0000884629operating
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 2:51 PM ET
Size
7.6 KB
Accession
0001179110-05-019121
Insider Transaction Report
Form 4
HSIA DAVID C
Sr. VP, Scientific Affairs
Transactions
- Gift
Common Stock, par value $0.0033
2005-09-30−5,500→ 732,964 total(indirect: By Trust)
Holdings
- 1,004,218(indirect: By Partnership)
Common Stock, par value $0.0033
- 40,000(indirect: By Trust)
Common Stock, par value $0.0033
- 61,333
Common Stock, par value $0.0033
Footnotes (3)
- [F1]By Family Trust refers to the Hsia Family Trust, of which Dr. Hsia is a beneficial owner.
- [F2]By Partnership refers to the Hsia Interests, Ltd., of which Dr. Hsia is a general partner.
- [F3]This includes 1,333 shares of restricted stock issued pursuant to the Amendment and Restatement of the 2001 Incentive Award Plan of Watson Pharmaceuticals, Inc.
Documents
Issuer
WATSON PHARMACEUTICALS INC
CIK 0000884629
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0000884629
Filing Metadata
- Form type
- 4
- Filed
- Oct 3, 8:00 PM ET
- Accepted
- Oct 4, 2:51 PM ET
- Size
- 7.6 KB